{
  "title": "Zuranolone for Postpartum Depression",
  "itunes:title": "Zuranolone for Postpartum Depression",
  "pubDate": "Tue, 17 May 2022 16:00:29 +0000",
  "guid": "17c6c5e0-dfe3-44ed-81d4-a1f93d50fd64",
  "link": "https://psychopharmacology.libsyn.com/zuranolone-for-postpartum-depression",
  "itunes:image": "",
  "description": "<p>Should zuranolone be a first-line treatment for postpartum depression? In this episode, Dr. Phelps discusses a randomized trial of zuranolone—a new neuromodulatory steroid—in the context of previous guidelines for the treatment of postpartum depression. </p> <p>Faculty: Jim Phelps, M.D. <br /> Host: Jessica Diaz, M.D.</p> <ul> <li><strong><a href= \"https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC159\"> Learn more about our memberships here</a></strong></li> <li><strong><a href= \"https://psychopharmacologyinstitute.com/publication/quick-take-vol-35-2632?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC159\"> Earn 0.5 CMEs: Quick Take Vol. 35</a><br /></strong></li> <li><strong><a href= \"https://psychopharmacologyinstitute.com/section/effect-of-zuranolone-vs-placebo-in-postpartum-depression-2632-5166?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC159\"> Effect of Zuranolone vs Placebo in Postpartum Depression</a></strong></li> </ul> <p> </p>",
  "content:encoded": "<p>Should zuranolone be a first-line treatment for postpartum depression? In this episode, Dr. Phelps discusses a randomized trial of zuranolone—a new neuromodulatory steroid—in the context of previous guidelines for the treatment of postpartum depression. </p> <p>Faculty: Jim Phelps, M.D.  Host: Jessica Diaz, M.D.</p> <ul> <li><a href= \"https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC159\"> Learn more about our memberships here</a></li> <li><a href= \"https://psychopharmacologyinstitute.com/publication/quick-take-vol-35-2632?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC159\"> Earn 0.5 CMEs: Quick Take Vol. 35</a></li> <li><a href= \"https://psychopharmacologyinstitute.com/section/effect-of-zuranolone-vs-placebo-in-postpartum-depression-2632-5166?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC159\"> Effect of Zuranolone vs Placebo in Postpartum Depression</a></li> </ul> <p> </p>",
  "enclosure": "",
  "itunes:duration": "09:23",
  "itunes:explicit": false,
  "itunes:keywords": "",
  "itunes:subtitle": "Should zuranolone be a first-line treatment for postpartum depression? In this episode, Dr. Phelps discusses a randomized trial of zuranolone—a new neuromodulatory steroid—in the context of previous guidelines for the treatment of postpartum...",
  "itunes:episodeType": "full"
}